Policy / Pricing FDA Releases Congressional Justification for FY 2027 Budget, Including Proposal Regarding Interchangeability of Biosimilars Big Molecule WatchThe U.S.Policy / PricingRead full story pharminent April 22, 2026 (Last updated: April 23, 2026) Big Molecule Watch The U.S. Policy / PricingRead full story Post navigation Previous: Medicare weight loss drug pilot on ice as insurers decline to contributeNext: AbbVie makes record investment in North Carolina plant Related Stories Policy / Pricing MFN affecting Swiss medicines access, says Interpharma pharminent August 13, 2026 Policy / Pricing Prior Authorization Metrics Provide New Insights into Insurer Practices, but Gaps Remain pharminent August 13, 2026 Policy / Pricing Trump signs order that nearly halves childhood immunisation coverage pharminent August 11, 2026
